- Home
- WLDN vs NEO Comparison
WLDN vs NEO Comparison
Compare WLDN & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WLDN | NEO |
|---|---|---|
| Founded | 1964 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2006 | 2008 |
Fundamental Metrics
Financial Performance| Metric | WLDN | NEO |
|---|---|---|
| Price | $93.00 | $8.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $114.50 | $13.38 |
| AVG Volume (30 Days) | 419.3K | ★ 2.2M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.89 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $273,352,000.00 | N/A |
| Revenue This Year | N/A | $10.63 |
| Revenue Next Year | $12.05 | $9.73 |
| P/E Ratio | $170.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $45.24 | $4.72 |
| 52 Week High | $137.00 | $13.74 |
Technical Indicators
Market Signals| Indicator | WLDN | NEO |
|---|---|---|
| Relative Strength Index (RSI) | 66.13 | 50.73 |
| Support Level | $74.08 | $8.68 |
| Resistance Level | $100.15 | $8.84 |
| Average True Range (ATR) | 5.63 | 0.59 |
| MACD | 2.52 | 0.01 |
| Stochastic Oscillator | 84.72 | 38.07 |
Price Performance
Historical ComparisonAbout WLDN Willdan Group Inc.
Willdan Group Inc is a provider of professional technical and consulting services to utilities, private industry, and public agencies at all levels of government. It operates in the business segments of Energy and Engineering and Consulting. It generates the majority of its revenue from the Energy segment, which includes services such as audit and surveys, program design, master planning, benchmarking analysis, design engineering, construction management, performance contracting, installation, advances in software and data analytics, and other services. All of its revenue is derived from the domestic markets.
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.